Physician profile
Charles P Springer
NPI 1356344576
$20,140.48
in general payments reported to CMS, 2019-2025
12 companies · $3,933 in 2025
The $3,933 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,696 · 2020: $724 · 2021: $217 · 2022: $1,375 · 2023: $5,929 · 2024: $5,268 · 2025: $3,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Food and Beverage: $1,000 · Travel and Lodging: $228 · Long Term Medical Supply Or Device Loan: $84.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,816.16 |
| Food and Beverage | $1,000.45 |
| Travel and Lodging | $227.82 |
| Long Term Medical Supply Or Device Loan | $84.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $13,816.16 | 2023-2025 | Djo Surgical |
| Arthrex, INC. | $2,952.49 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,156.34 | 2019-2025 | Oxford, Persona, Mymobility Platform |
| Lima USA, INC. | $954.96 | 2019 | |
| Heron Therapeutics, INC. | $346.17 | 2021-2024 | Zynrelef |
| Limacorporate S.P.A. | $192.32 | 2019 | |
| Sanara Medtech INC. | $174.13 | 2025 | Celleraterx |
| Globus Medical, INC. | $122.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $120.10 | 2025 | |
| Coastal Medical Technologies LLC | $114.32 | 2023 | |
| Mvp Orthopedics INC | $106.09 | 2022 | |
| Baxter Healthcare | $84.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.